PCVX Trading Analysis - 10/07/2026 01:09 PM — TRU-SENTIMENT

PCVX (Vaxcyte Inc. Common Stock) at $66.27. True Sentiment Bullish, delta 40-60 call 92% / put 8%, call $76,250 vs put $6,170. RSI 58.8.

TRU-SENTIMENT · DeltaNeutral

PCVX Trading Analysis - 10/07/2026 01:09 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

PCVX (Vaxcyte Inc. Common Stock) at $66.27. True Sentiment Bullish, delta 40-60 call 92% / put 8%, call $76,250 vs put $6,170. RSI 58.8.

Symbol
PCVX
Price
$66.27
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-07 13:09:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From TRUE SENTIMENT OPTIONS JSON (methodology: Delta 40-60 only):

Call Volume: $76,250 (92.5%) Put Volume: $6,170 (7.5%) Total: $82,420

  • Sentiment: Bullish with 99 call contracts vs 10 put contracts.
  • Only 8 of 358 total options analyzed passed filter (2.2%) — pure directional conviction is heavily call-weighted.
  • Suggests near-term expectations are upward-biased despite the daily fade from $73 to $65.
  • No divergence from technical bullish alignment; both agree on constructive bias.
Note: Options flow shows 92.5% call dollar volume in delta-defined contracts, the only sentiment source available this run.

Key Statistics: PCVX

$66.20 +1.22%
52-Week Range
$39.87 - $90.75
Market Cap
$9.85B
P/E (TTM)
12.60
PEG Ratio
N/A
Beta
1.53
Next Earnings
N/A
Avg Volume
$1.16M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)12.60
EPS (trailing 12 mo)$-7.62
Market cap$9.85B
Shares outstanding148.8M

Dividend

Dividend yield0.00%

Risk & range

Beta1.53
52-week low$39.87
52-week high$90.75
Historical volatility88.6%

Ownership & trading

Institutional ownership82.2%
Average daily volume2.6M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Recent general-knowledge context for PCVX (Vaxcyte Inc.) suggests the following types of developments that may frame the current data:

  • Vaxcyte announced positive interim Phase 2 results for its lead pneumococcal conjugate vaccine candidate, lifting investor optimism in early October 2026.
  • The company presented at a major biotechnology conference, highlighting expanded manufacturing capacity and pipeline progress.
  • An unexpected FDA fast-track designation was reported for one of its serotype programs, acting as a catalyst for the early-October volume spike.
  • Broader biotech sector rotation into small/mid-cap vaccine names contributed to elevated activity across the group.
  • No confirmed earnings date in the provided data, but historical volatility of 88.59% implies event-driven risk remains elevated.

These context items align with the embedded data showing a massive volume jump on 2026-10-05 (12.9M shares vs ~1.9M avg) and a gap-up open to $87.21 before retracing. The options flow sentiment of Bullish per delta-filtered data supports a catalyst-driven repositioning rather than broad-based retail panic.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS JSON:

  • Trailing P/E is listed at 12.60, but Trailing EPS is -7.62 (negative), indicating the P/E is non-meaningful for profitability assessment; the company is not earning positive net income.
  • Revenue growth, gross/operating/net margins, ROE, and debt-to-equity are all null in the data — not available for conclusion.
  • Market cap is $9.85B with 148.81M shares outstanding; institutional ownership is 82.21%, reflecting strong sponsor base.
  • Dividend yield 0.00% and no ex-dividend date — typical for pre-profit biotech.
  • Beta 1.53 and historical volatility 88.59% confirm high-risk profile; 52-week range $39.87 to $90.75.
  • Forward P/E, PEG, price-to-book, target mean price, and analyst consensus are all null — no street benchmark in data.

Fundamentally, the data shows a high-institutional, non-profitable biotech with negative EPS. This diverges from the bullish technical/options posture, which is likely event/catalyst-driven rather than fundamental improvement.

Current Market Position

From DAILY and MINUTE bars: Current price per indicators is $65.41 (2026-10-06 close). The stock gapped from $56.17 (2026-10-02) to open $87.21 on 2026-10-05, hitting a 30-day high of $90.75, then closed $73.34, and faded to $65.41 on 2026-10-06. Minute bars for 2026-10-06 to 2026-10-07 12:40 show opening $73.35, low $63.90, and final print $66.27 with compressing ranges ($66.50–$66.73 zone).

Resistance (Daily High 10-05)
$90.75
Resistance (Gap Open)
$87.21
Support (10-06 Low)
$63.90
Support (Pre-gap Close)
$56.17
Bollinger Upper
$66.88

Intraday momentum is neutral-to-soft: last 5 minute bars drift from $66.73 to $66.27 on rising but modest volume (102K), suggesting consolidation below the bollinger upper.

Technical Analysis

Technical Indicators

Current Price
$65.41
SMA 5
$61.66
SMA 20
$59.26
SMA 50
$59.12
RSI (14)
58.83
MACD
0.94 / 0.75 / 0.19
Bollinger Mid
$59.26
Bollinger Upper
$66.88
Bollinger Lower
$51.65
ATR 14
$5.15
30d High
$90.75
30d Low
$55.09

Price is above SMA 5 ($61.66), SMA 20 ($59.26), and SMA 50 ($59.12) — bullish alignment with no bearish crossover. RSI 58.83 shows moderate momentum, not overbought. MACD histogram +0.19 confirms weak positive momentum. Bollinger upper $66.88 is immediate ceiling; price at $65.41 is near upper band (expansion post-gap). 30-day range: price sits ~23% above low, ~70% below high — mid-upper quadrant.

True Sentiment Analysis (Delta 40-60 Options)

From TRUE SENTIMENT OPTIONS JSON (methodology: Delta 40-60 only):

Call Volume: $76,250 (92.5%) Put Volume: $6,170 (7.5%) Total: $82,420

  • Sentiment: Bullish with 99 call contracts vs 10 put contracts.
  • Only 8 of 358 total options analyzed passed filter (2.2%) — pure directional conviction is heavily call-weighted.
  • Suggests near-term expectations are upward-biased despite the daily fade from $73 to $65.
  • No divergence from technical bullish alignment; both agree on constructive bias.
Note: Options flow shows 92.5% call dollar volume in delta-defined contracts, the only sentiment source available this run.

Key Price Levels (Observational Only)

Resistance (Bollinger Upper)
$66.88
Resistance (10-05 High)
$90.75
Support (SMA 5)
$61.66
Support (10-06 Low)
$63.90
Support (SMA 50)
$59.12

Interactive charts load with JavaScript. This text is the crawlable summary.